DURECT Corporation to Participate in Three Investor Conferences in March 2021

On March 3, 2021 DURECT Corporation (Nasdaq: DRRX) reported that it will partipate in three upcoming investor conferences, taking place in March 2021 (Press release, DURECT, MAR 3, 2021, https://www.prnewswire.com/news-releases/durect-corporation-to-participate-in-three-investor-conferences-in-march-2021-301240108.html [SID1234576033]). All conferences will take place virtually.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details are as follow:

H.C. Wainwright Life Sciences Conference: March 9 – 10

Presentation Date:

March 9

Time:

Available on demand from 7:00 am (EST)

Webcast:

Register Here

ROTH Conference: March 15 – 17

Presentation Date:

March 5

Time:

Available on demand from 5:00 pm (EST)

Webcast:

Register Here

Oppenheimer & Co. Healthcare Conference: March 16 – 18

Presentation Date:

March 17

Time:

11:20 a.m. EST

Webcast:

Register Here

The webcast links and replay links of the presentations will also be available by accessing DURECT’s homepage at www.durect.com and clicking on the "Investors" tab. If you are unable to participate during conferences, the calls will be archived on DURECT’s website under "Event Calendar" in the "Investors" section.